Full Text
Full text is available in PDF
Jentashapir Journal of Cellular and Molecular Biology
Official Journal of Ahvaz Jundishapur University of Medical Sciences
Long-term follow-up for the results of the treatment with Anti-Thyroid Drugs, Radioactive iodine and surgery in patients with Graves, disease
Author(s):
Published online:Oct 31, 2014
Article type:Letter
Received:Jul 15, 2012
Accepted:Dec 29, 2012
How to Cite:
Abstract
This article does not have abstract.
Keywords
In a retrospective study
580 patients with Graves disease were evaluated. They were treated with one of the treatment methods from October 1999 until September 2005. Using a questionnaire that related data were collected: demographic information
onset of disease
the recurrence rate incidence of hyperthyroidism and side effects of treatment were collected. Out of 580 patients enrolled the study
268 (46%) were treated with anti-thyroid drugs (for 18 months at least)
284 (49%) with radioactive iodine and 28 (5%) underwent the surgery. Recurrence rates of hyperthyroidism after treatment with anti-thyroid drugs
iodine therapy and surgery were recorded at 53%
8%
14%
respectively (P<
0/001). Hypothyroidism occurence after three methods was 6%
74% and 71%
respectively. Overall
Copyright
© 2014, Jentashapir Journal of Cellular and Molecular Biology. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
27
Jun
2020
Management of Graves’ Hyperthyroidism: More Than a Century of Progression
Hengameh Abdi,
Atieh Amouzegar
Abdi H, Amouzegar A. Management of Graves’ Hyperthyroidism: More Than a Century of Progression. Int J Endocrinol Metab. 2020;18(Suppl):e103943. doi: https://doi.org/10.5812/ijem.103943
14
Jun
2020
Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease
Ken Okamura,
Sachiko Bandai,
Megumi Fujikawa,
Kaori Sato,
Hiroshi Ikenoue,
Takanari Kitazono
Okamura K, Bandai S, Fujikawa M, Sato K, Ikenoue H, et al. Long-Term Antithyroid Drug Treatment: Trends in Serum TSH and TSH Receptor Antibody Changes in Patients with Graves’ Disease. Int J Endocrinol Metab. 2020;18(Suppl):e101139. doi: https://doi.org/10.5812/ijem.101139
31
Jan
2026
Sustained Control of Hyperthyroidism in Graves’ Disease: Comparison of Thyroidectomy and Long-Term Antithyroid Treatment
Hengameh Abdi,
Miralireza Takyar,
Ladan Mehran,
Safdar Masoumi,
Atieh Amouzegar,
Fereidoun Azizi
Abdi H, Takyar M, Mehran L, Masoumi S, Amouzegar A, et al. Sustained Control of Hyperthyroidism in Graves’ Disease: Comparison of Thyroidectomy and Long-Term Antithyroid Treatment. Int J Endocrinol Metab. 2026;24(1):e164940. doi: https://doi.org/10.5812/ijem-164940
31
Mar
2005
The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents
S Kalantary
Kalantary S. The prevalence of Graves’ disease and related factors recurrence following discontinuation of antithyroid agents. J Inflamm Dis. 2024;8(4):e155096. doi:
13
Jun
2020
Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment
Danilo Villagelin,
Roberto Bernardo Santos,
João Hamilton Romaldini
Villagelin D, Santos RB, Romaldini JH. Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment. Int J Endocrinol Metab. 2020;18(Suppl):e101473. doi: https://doi.org/10.5812/ijem.101473
Download PDF60.18 KB
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 2 hours ago
- Scopus by Title: 0
Last Update: 10 months ago
- Scopus by Title (Ref): 0
Last Update: 11 years ago
- CrossRef: 0
Last Update: 23 hours ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles